Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ABVE vs HDSN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HDSN Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 9–1 Matrix Metrics)

HDSN Overall Winner 6-Pillar Tally: ABVE 2 – 4 HDSN Matrix Metrics: ABVE 1 – 9 HDSN

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas HDSN carries 53.2/100 (HOLD) at $4.25 (25.9x Forward P/E, 2.0% operating margin).

  • Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABVE vs HDSN
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67
HDSN NASDAQ Head-to-Head Winner
Hudson Technologies Inc
Wholesale-Machinery, Equipment & Supplies
$4.25
-3.52% 1D
Market Cap $186.5M
TTM Revenue $242M
Forward P/E 25.9x
Beta / 30D Vol 1.32β · 68% Vol
Unified Composite Score
53.2 / 100 HOLD
Tech 67.0 Fund 65.0 Flow 55.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $4.68 · SMA50: $4.99

6-Pillar Scorecard Institutional Category Breakdown (ABVE 2 – 4 HDSN)

Columns: Metric · ABVE · HDSN
1. Valuation Multiples HDSN
Forward P/E N/M 25.9x
Trailing P/E N/M 16.5x
PEG Ratio N/M 0.29x
EV / Revenue 0.1x 0.6x
2. Growth & Scale HDSN
Revenue Growth (YoY) -45.0% -19.7%
Earnings Growth (YoY) +0.0% -82.0%
TTM Revenue (USD) $295M $242M
Market Cap $30.0M $186.5M
3. Profitability & Quality HDSN
Gross Margin -2.8% 21.0%
Operating Margin -23.2% 2.0%
Net Profit Margin -23.4% -0.5%
Return on Equity (ROE) 0.0% -0.5%
4. Balance Sheet & Cash Flow HDSN
Cash Generation (TTM) -$40M EBITDA -$32M
Cash Flow Margin -13.7% EBITDA Mgn -13.0%
Net Cash / Leverage 0.0% ROE $31M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABVE
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 148.3% (8th %ile) 79.1% (15th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat ABVE
OpEx & R&D Intensity 20.4% of Rev ($60M) 19.0% of Rev ($46M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABVE (1) vs HDSN (9)
Institutional Metric ABVE HDSN Criterion Row Edge
Market Capitalization
Scale
$30.0M $186.5M Larger Scale HDSN
Trailing P/E Ratio
Valuation
N/M 16.5x Lower Multiple HDSN
Forward P/E Ratio
Valuation
N/M 25.9x Lower Multiple HDSN
Revenue Growth (YoY)
Growth
-45.0% -19.7% Higher Growth HDSN
Operating Margin (TTM)
Profitability
-23.2% 2.0% Higher Margin HDSN
Net Profit Margin
Profitability
-23.4% -0.5% Higher Margin HDSN
Return on Equity (ROE)
Capital Efficiency
0.0% -0.5% Higher ROE ABVE
52-Week Range Position
Momentum
0% ($0–$7) 6% ($4–$8) Stronger Trend HDSN
Beta / 30D Volatility
Risk Regime
4.10β · 310% Vol 1.32β · 68% Vol Lower Realized Risk HDSN
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 53.2 / 100 (HOLD) Higher Composite HDSN
Trailing 12M Revenue (USD)
Operating Scale
$295M $242M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-2.8% 21.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev 0.29x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$40M EBITDA (0.0% ROE) -$32M ($31M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HDSN +62.89 pp
ABVE: -79.18% · HDSN: -16.29%
3M Horizon HDSN +63.61 pp
ABVE: -91.43% · HDSN: -27.82%
6M Horizon HDSN +72.17 pp
ABVE: -95.67% · HDSN: -23.5%
1Y Horizon HDSN +70.76 pp
ABVE: -94.38% · HDSN: -23.62%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs HDSN. Trailing 12-month operating profitability (ABVE -23.2% vs HDSN 2.0%) and valuation multiples (ABVE N/M vs HDSN 25.9x Forward P/E) are benchmarked directly in Pillar 4 below.

ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M
HDSN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$242M
Gross Margin21.0%
Op. Margin2.0%
ROE / Fwd P/E-0.5% · 25.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HDSN BREAKDOWN
90d in phase · OBV ACCUMULATION
Current IV 79.1%
IV Percentile 15th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published
HDSN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $186.5M market capitalization and 2.0% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($46M)
90D Engineering Disclosures 0 Published

Investor FAQ ABVE vs HDSN Key Questions & Quantitative Answers

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas HDSN carries 53.2/100 (HOLD) at $4.25 (25.9x Forward P/E, 2.0% operating margin). Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HDSN leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with HDSN at -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $242M for HDSN. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($46M) (0 disclosures) for HDSN.

HDSN screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus HDSN (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.